GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (OTCPK:PSYGD) » Definitions » Other Gross PPE

PSYGD (Psyence Group) Other Gross PPE : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Psyence Group Other Gross PPE?

Psyence Group's Other Gross PPE for the quarter that ended in Dec. 2024 was $0.00 Mil.

Psyence Group's annual Other Gross PPE declined from Mar. 2022 ($0.11 Mil) to Mar. 2023 ($0.11 Mil) but then increased from Mar. 2023 ($0.11 Mil) to Mar. 2024 ($1.08 Mil).


Psyence Group Other Gross PPE Historical Data

The historical data trend for Psyence Group's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Group Other Gross PPE Chart

Psyence Group Annual Data
Trend Dec19 Dec20 Mar22 Mar23 Mar24
Other Gross PPE
- - 0.11 0.11 1.08

Psyence Group Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 1.08 - - -

Psyence Group Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Psyence Group Business Description

Traded in Other Exchanges
Address
121 Richmond Street West, Penthouse Suite, 1300, Toronto, ON, CAN, M5H 2K1
Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.

Psyence Group Headlines

No Headlines